<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>14</volume><submitter>Li N</submitter><pubmed_abstract>&lt;b>Objective:&lt;/b> The aim of this study was to confirm the potential role of testosterone in hypertension and target organ damage (TOD) in hypertensive postmenopausal women. &lt;b>Methods:&lt;/b> A matched group study was conducted. One hundred sixty-one hypertensive postmenopausal women between 45 and 65 years of age were enrolled as group 1. Another 161 age-matched hypertensive men were enrolled as group 2. Ambulatory blood pressure monitoring, echocardiographic imaging, vascular function, sex hormones and clinical characteristics were evaluated. Quantitative data were analyzed using independent Student's &lt;i>t&lt;/i>-test and multiple regression analysis. &lt;b>Results:&lt;/b> The mean and load level of blood pressure were lower in women than in men (&lt;i>P&lt;/i>&lt;0.05), except for the mean level and load of the nocturnal systolic blood pressure (SBP) (123.77±15.72 mmHg vs 126.35±15.64 mmHg, and 50.43±30.31% vs 55.35±28.51%, &lt;i>P&lt;/i>>0.05). However, the carotid-femoral pulse wave velocity (cf-PWV) in women was higher than that in men (9.68±2.23 m/s vs 8.03±2.82 m/s, &lt;i>P&lt;/i>&lt;0.05). The ratio of the early diastolic mitral peak flow velocity to early diastolic mitral annular velocity (E/Em) was obviously impaired (13.06±3.53 vs 12.05±3.68, &lt;i>P&lt;/i>&lt;0.05) in women. Furthermore, in women, a positive correlation was found between testosterone and cf-PWV (γ=0.157, &lt;i>P&lt;/i>=0.046), and Cf-PWV was positively related to the mean level of nighttime SBP (γ=0.210, &lt;i>P&lt;/i>=0.008). Moreover, nocturnal SBP was a risk factor for E/Em (γ=0.156, &lt;i>P&lt;/i>=0.048, &lt;i>P&lt;/i>&lt;0.05). &lt;b>Conclusion:&lt;/b> Testosterone may play a role in the correlation between hypertension and TOD in hypertensive postmenopausal women. &lt;b>Clinical Trial number:&lt;/b> This research study was registered under the ClinicalTrials.gov PRS Website (NCT03451747).</pubmed_abstract><journal>Clinical interventions in aging</journal><pagination>743-752</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC6501555</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>The potential role of testosterone in hypertension and target organ damage in hypertensive postmenopausal women.</pubmed_title><pmcid>PMC6501555</pmcid><pubmed_authors>Ma R</pubmed_authors><pubmed_authors>Yang Z</pubmed_authors><pubmed_authors>Ding H</pubmed_authors><pubmed_authors>Wang P</pubmed_authors><pubmed_authors>Wang S</pubmed_authors><pubmed_authors>Yu J</pubmed_authors><pubmed_authors>Zhao Y</pubmed_authors><pubmed_authors>Li N</pubmed_authors><pubmed_authors>Jin L</pubmed_authors><pubmed_authors>Zhang P</pubmed_authors><pubmed_authors>Bai F</pubmed_authors></additional><is_claimable>false</is_claimable><name>The potential role of testosterone in hypertension and target organ damage in hypertensive postmenopausal women.</name><description>&lt;b>Objective:&lt;/b> The aim of this study was to confirm the potential role of testosterone in hypertension and target organ damage (TOD) in hypertensive postmenopausal women. &lt;b>Methods:&lt;/b> A matched group study was conducted. One hundred sixty-one hypertensive postmenopausal women between 45 and 65 years of age were enrolled as group 1. Another 161 age-matched hypertensive men were enrolled as group 2. Ambulatory blood pressure monitoring, echocardiographic imaging, vascular function, sex hormones and clinical characteristics were evaluated. Quantitative data were analyzed using independent Student's &lt;i>t&lt;/i>-test and multiple regression analysis. &lt;b>Results:&lt;/b> The mean and load level of blood pressure were lower in women than in men (&lt;i>P&lt;/i>&lt;0.05), except for the mean level and load of the nocturnal systolic blood pressure (SBP) (123.77±15.72 mmHg vs 126.35±15.64 mmHg, and 50.43±30.31% vs 55.35±28.51%, &lt;i>P&lt;/i>>0.05). However, the carotid-femoral pulse wave velocity (cf-PWV) in women was higher than that in men (9.68±2.23 m/s vs 8.03±2.82 m/s, &lt;i>P&lt;/i>&lt;0.05). The ratio of the early diastolic mitral peak flow velocity to early diastolic mitral annular velocity (E/Em) was obviously impaired (13.06±3.53 vs 12.05±3.68, &lt;i>P&lt;/i>&lt;0.05) in women. Furthermore, in women, a positive correlation was found between testosterone and cf-PWV (γ=0.157, &lt;i>P&lt;/i>=0.046), and Cf-PWV was positively related to the mean level of nighttime SBP (γ=0.210, &lt;i>P&lt;/i>=0.008). Moreover, nocturnal SBP was a risk factor for E/Em (γ=0.156, &lt;i>P&lt;/i>=0.048, &lt;i>P&lt;/i>&lt;0.05). &lt;b>Conclusion:&lt;/b> Testosterone may play a role in the correlation between hypertension and TOD in hypertensive postmenopausal women. &lt;b>Clinical Trial number:&lt;/b> This research study was registered under the ClinicalTrials.gov PRS Website (NCT03451747).</description><dates><release>2019-01-01T00:00:00Z</release><publication>2019</publication><modification>2024-11-21T04:33:41.256Z</modification><creation>2019-06-06T23:27:35Z</creation></dates><accession>S-EPMC6501555</accession><cross_references><pubmed>31118595</pubmed><doi>10.2147/CIA.S195498</doi></cross_references></HashMap>